Heron Therapeutics is trading at $0.30, up 5.34%, amid a biotech-sector rally. - XBI rose 2.13% as investors rotated toward biotech stocks; broader markets also advanced. - No verified company-specific announcement explained the November 4 move. Available information does not establish a more specific catalyst or confirm unusual trading activity. - Heron Therapeutics’ next scheduled earnings report is November 9.